Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
US6716829B2 · kind B2 · utility
4Cited by
31References
68Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2001 |
| Grant date | Apr 6, 2004 |
| Priority date | — |
| Expiry date | Jul 26, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/585
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Combinations of aldosterone blockers and Cyclooxygenase-2 inhibitors useful in the treatment of inflammation are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.